3rd Annual AF Virtual Run/Walk/Roll

May 01

3rd Annual AF Virtual Run/Walk/Roll

May 1, 2021  - July 31, 2021


** EXTENDED ** Now through August 31st!!


A virtual run is a run that can be run (walked or rolled) from any location you choose. You can run, jog, walk or bike on the road, on the trail, on the treadmill, at the gym, or on the track. You get to run your own race, at your own pace, and time it yourself. 

Sign Up for the “Run for Your Life” Virtual Run

Registration for the Virtual Run is currently open.

  • 5K Run – $25.00
  • 10K Run – $35.00

Register Here

Or call the office to register at 248-922-9610.

Once you have signed up for the run, either a 5K or 10K, then decide on the course you want to do, or you can do it on the treadmill. You time yourself. You can even get your friends and/or your kids to run with you too. The run should be completed between May 1, 2022, and July 31, 2022.

Don’t forget to share the run with your friends and family!

Take Photos and Share Your Run with Us

Once you have completed your run, send us some photos to share with [email protected]

We would love to hear about your run! Join our Amyloidosis Facebook page and Instagram page. #AFVirtualRun #AFVirtualRun2022 #VirtualRun2022

2021 Giving Tuesday

Nov 03

2021 Giving Tuesday

November 3, 2021  - December 1, 2021



On November 30, 2021, people all around the world are coming together to tap into the power of human connection and strengthen communities and change our world. Will you be one of them? 

Amyloidosis Foundation will be participating in GivingTuesday and we need your help! 

By joining the GivingTuesday movement, you’re proving that in times of uncertainty, generosity can bring the whole world together. 

Here is how you can get ready to give:

  1. Mark your calendar 
  2. Give. On November 30, go to our donation link and give.
  3. Spread the word. Encourage your friends and family to join you in creating real impact on November 30 by sharing what our mission means to you and why you support our organization. Make sure to use hashtag #GivingTuesday and tag us so we can share!

Let’s rally together to build stronger communities. 

The Amyloidosis Foundation is a non-profit organization that supports research through our annual grant program. Our mission is to raise awareness of the disease within the medical community and the public, in addition to providing education, information, and support for patients and their families. 

In 2020, we raised over $15,000. This year our goal is $20,000 and we need your help!

Those who are interested in joining Amyloidosis Foundation’s #GivingTuesday initiative can click here.

Together we give. Share your #UNSELFIE. Use our template and share it on Facebook, Instagram, and Twitter.

Webinar: “Progress in Amyloidosis: 2022”

Jul 13

Webinar: “Progress in Amyloidosis: 2022”

July 13, 2022

2:30 pm ET


July 2022 Live Webinar Event

Please join us for our webinar event presented by Dr. Jeffrey Zonder


July 13, 2022, at 2:30 pm ET

Register Here

Dr. Zonder will describe recent advances in the management of AL amyloidosis; review approved therapies for ATTR amyloidosis and how they work, and discuss new classes of agents designed to help remove existing amyloid deposits.

Jeffrey Zonder, MD, is a Professor in the Departments of Oncology at the Barbara Ann Karmanos Cancer Institute (KCI) and Wayne State University School of Medicine. He is the Leader of the KCI Multiple Myeloma and Amyloidosis Multidisciplinary Team and Co-Leader of the Molecular Therapeutics Program. He is a member of the Steering Committee of the Multiple Myeloma Research Consortium and a medical advisor for the Amyloidosis Support Groups Networks. Dr. Zonder is a member of the International Myeloma Working Group, the International Myeloma Society, and the International Society of Amyloidosis.  He is a member of the Southwest Oncology Group’s (SWOG) Barlogie-Salmon Myeloma Committee. Dr. Zonder has authored or co-authored numerous original research papers, review articles, book chapters, and research abstracts on myeloma and amyloidosis.

He completed a fellowship in hematology-oncology at Wayne State University and his medical residency at the University of Rochester, New York.  He received his medical degree from Wayne State University School of Medicine.

Sponsored by: